Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Hepatic granulomas

INTRODUCTION

Granulomas can be present in the liver in a variety of conditions. Their detection in the liver may be the first clue to an ongoing systemic disease. Although the granulomas themselves rarely cause structural liver damage, it is important to identify the underlying systemic disease since it might have prognostic and therapeutic implications. Careful consideration of associated clinical symptoms and characterization of the appearance and localization of the granulomas within the liver usually leads to a definitive diagnosis.

HISTOPATHOLOGY

A granuloma is a circumscribed lesion that forms as a result of an inflammatory reaction in body tissues. It is characterized by a central accumulation of mononuclear cells, primarily macrophages, with a surrounding rim consisting of lymphocytes and fibroblasts. The lesions are distinct from nearby uninvolved tissue (picture 1).

Early in the development of the granuloma, lesions may appear as punched-out clusters of histiocytes or lymphocytes. The granulomas evolve with stimulation of mononuclear cells from a variety of cytokines. Activated macrophages are transformed to resemble epithelial cells (referred to as epithelioid cells), which characteristically have abundant, pale cytoplasm. Adjacent macrophages may fuse, forming multinucleated giant cells. Granulomas infiltrated by eosinophils are suggestive of a drug reaction or parasitic infection.

The cells within the granuloma are capable of secreting a variety of proteins. As an example, epithelioid cells from patients with sarcoidosis secrete lysozyme, collagenase, and angiotensin converting enzyme (ACE). Elevated serum levels of ACE are characteristic of active sarcoidosis [1]. (See "Clinical manifestations and diagnosis of pulmonary sarcoidosis".)

The histologic features of the granulomas and their location may be helpful for narrowing the differential diagnosis. Four histologic variants of hepatic granulomas have been recognized, the first two of which are most common in the United States [2]:

                

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jun 2014. | This topic last updated: Jan 24, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Ishak KG. Granulomas of the liver. Adv Pathol Lab Med 1995; 8:247.
  2. Maddrey WC. Granulomas of the liver. In: Schiff's Diseases of the Liver, Eighth Edition, Schiff ER, Sorrell MF, Maddrey WC (Eds), Lippincott-Raven, Philadelphia 1989. p.1572.
  3. Drebber U, Kasper HU, Ratering J, et al. Hepatic granulomas: histological and molecular pathological approach to differential diagnosis--a study of 442 cases. Liver Int 2008; 28:828.
  4. KLATSKIN G, YESNER R. Hepatic manifestations of sarcoidosis and other granulomatous diseases; a study based on histological examination of tissue obtained by needle biopsy of the liver. Yale J Biol Med 1950; 23:207.
  5. Tahan V, Ozaras R, Lacevic N, et al. Prevalence of hepatic granulomas in chronic hepatitis B. Dig Dis Sci 2004; 49:1575.
  6. Zakim, D, Boyer, TD. Hepatology, A Textbook of Liver Diseases, Vol 3, 3rd ed, WB Saunders, Philadelphia 1996. p.1472.
  7. Magill AJ, Grögl M, Gasser RA Jr, et al. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 1993; 328:1383.
  8. Klatskin G. Hepatic granulomata: problems in interpretation. Mt Sinai J Med 1977; 44:798.
  9. Alvarez SZ, Carpio R. Hepatobiliary tuberculosis. Dig Dis Sci 1983; 28:193.
  10. Hofmann CE, Heaton JW Jr. Q fever hepatitis: clinical manifestations and pathological findings. Gastroenterology 1982; 83:474.
  11. Marazuela M, Moreno A, Yebra M, et al. Hepatic fibrin-ring granulomas: a clinicopathologic study of 23 patients. Hum Pathol 1991; 22:607.
  12. Ruel M, Sevestre H, Henry-Biabaud E, et al. Fibrin ring granulomas in hepatitis A. Dig Dis Sci 1992; 37:1915.
  13. Vanderstigel M, Zafrani ES, Lejonc JL, et al. Allopurinol hypersensitivity syndrome as a cause of hepatic fibrin-ring granulomas. Gastroenterology 1986; 90:188.
  14. Akritidis N, Tzivras M, Delladetsima I, et al. The liver in brucellosis. Clin Gastroenterol Hepatol 2007; 5:1109.
  15. Kadin ME, Donaldson SS, Dorfman RF. Isolated granulomas in Hodgkin's disease. N Engl J Med 1970; 283:859.
  16. Braylan RC, Long JC, Jaffe ES, et al. Malignant lymphoma obscured by concomitant extensive epithelioid granulomas: report of three cases with similar clinicopathologic features. Cancer 1977; 39:1146.
  17. Simon HB, Wolff SM. Granulomatous hepatitis and prolonged fever of unknown origin: a study of 13 patients. Medicine (Baltimore) 1973; 52:1.
  18. Knox TA, Kaplan MM, Gelfand JA, Wolff SM. Methotrexate treatment of idiopathic granulomatous hepatitis. Ann Intern Med 1995; 122:592.
  19. Guckian JC, Perry JE. Granulomatous hepatitis. An analysis of 63 cases and review of the literature. Ann Intern Med 1966; 65:1081.
  20. Cunnigham D, Mills PR, Quigley EM, et al. Hepatic granulomas: experience over a 10-year period in the West of Scotland. Q J Med 1982; 51:162.